Immunotherapy Based on Tumor Associated Antigen-specific Immune Effector Cells

NCT03535246 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

100

Enrollment

OTHER

Sponsor class

Conditions

Cancer

Interventions

BIOLOGICAL: Engineered Immune Cells

Sponsor

Shenzhen Geno-Immune Medical Institute